Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies : Recent Progress in Gene TherapyDAVILA, Marco L; BOUHASSIRA, Diana C. G; PARK, Jae H et al.International journal of hematology. 2014, Vol 99, Num 4, pp 361-371, issn 0925-5710, 11 p.Article

Generation of CD19-chimeric antigen receptor modified CD8⁺ T cells derived from virus-specific central memory T cellsTERAKURA, Seitaro; YAMAMOTO, Tori N; GARDNER, Rebecca A et al.Blood. 2012, Vol 119, Num 1, pp 72-82, issn 0006-4971, 11 p.Article

Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010ERTL, Hildegund C. J; ZAIA, John; ROSENBERG, Steven A et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 9, pp 3175-3181, issn 0008-5472, 7 p.Article

Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptorTONG ZHANG; BARBER, Amorette; SENTMAN, Charles L et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5927-5933, issn 0008-5472, 7 p.Article

Engineering T cells for cancer therapyMANSOOR, W; GILHAM, D. E; THISTLETHWAITE, F. C et al.British journal of cancer. 2005, Vol 93, Num 10, pp 1085-1091, issn 0007-0920, 7 p.Article

A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor CellsCHANG, Yu-Hsiang; CONNOLLY, John; SHIMASAKI, Noriko et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 6, pp 1777-1786, issn 0008-5472, 10 p.Article

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptorHUDECEK, Michael; SCHMITT, Thomas M; WOOD, Brent et al.Blood. 2010, Vol 116, Num 22, pp 4532-4541, issn 0006-4971, 10 p.Article

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCRTORIKAI, Hiroki; REIK, Andreas; LEE, Dean A et al.Blood. 2012, Vol 119, Num 24, pp 5697-5705, issn 0006-4971, 9 p.Article

The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer : Progress in Pediatric CancerLEE, Daniel W; BARRETT, David M; MACKALL, Crystal et al.Clinical cancer research (Print). 2012, Vol 18, Num 10, pp 2780-2790, issn 1078-0432, 11 p.Article

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD 19 chimeric-antigen-receptor-transduced T cellsKOCHENDERFER, James N; DUDLEY, Mark E; YANG, James C et al.Blood. 2012, Vol 119, Num 12, pp 2709-2720, issn 0006-4971, 12 p.Article

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinomaMACOR, Paolo; MEZZANZANICA, Delia; COSSETTI, Chiara et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3876-3883, issn 0008-5472, 8 p.Article

Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8⁺ Central Memory T Cells Manufactured at Clinical ScaleXIULI WANG; NARANJO, Araceli; JENSEN, Michael C et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 689-701, issn 1524-9557, 13 p.Article

IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen ExpressionCHMIELEWSKI, Markus; KOPECKY, Caroline; HOMBACH, Andreas A et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5697-5706, issn 0008-5472, 10 p.Article

Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivoLANDMEIER, S; ALTVATER, B; ROSSIG, C et al.Leukemia. 2010, Vol 24, Num 5, pp 1080-1084, issn 0887-6924, 5 p.Article

Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor― Modified T CellsKONG, Seogkyoung; SENGUPTA, Sadhak; JUNGHANS, Richard P et al.Clinical cancer research (Print). 2012, Vol 18, Num 21, pp 5949-5960, issn 1078-0432, 12 p.Article

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safetyHOYOS, V; SAVOLDO, B; QUINTARELLI, C et al.Leukemia. 2010, Vol 24, Num 6, pp 1160-1170, issn 0887-6924, 11 p.Article

Muscle CARs and TcRs: turbo-charged technologies for the (T cell) massesKALOS, Michael.Cancer immunology and immunotherapy. 2012, Vol 61, Num 1, pp 127-135, issn 0340-7004, 9 p.Article

Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody ReceptorMOON, Edmund K; CARPENITO, Carmine; JING SUN et al.Clinical cancer research (Print). 2011, Vol 17, Num 14, pp 4719-4730, issn 1078-0432, 12 p.Article

Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulinsLYTTON, S. D; LI, Y; OLIVO, P. D et al.Clinical and experimental immunology (Print). 2010, Vol 162, Num 3, pp 438-446, issn 0009-9104, 9 p.Article

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated TumorYANGBING ZHAO; MOON, Edmund; ALBELDA, Steven M et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 22, pp 9053-9061, issn 0008-5472, 9 p.Article

Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen ReceptorKOCHENDERFER, James N; FELDMAN, Steven A; YANGBING ZHAO et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 7, pp 689-702, issn 1524-9557, 14 p.Article

Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interactionTURATTI, Fabio; FIGINI, Mariangela; BALLADORE, Emanuela et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 7, pp 684-693, issn 1524-9557, 10 p.Article

Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimerasGROSS, Mor; BEN-CALIFA, Nathalie; MCMULLIN, Mary F et al.British journal of haematology. 2014, Vol 165, Num 4, pp 519-528, issn 0007-1048, 10 p.Article

Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptorSAHM, Christiane; SCHÖNFELD, Kurt; WELS, Winfried S et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 9, pp 1451-1461, issn 0340-7004, 11 p.Article

Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy : The Importance of Rational Chemotherapy of Chronic Lymphocytic LeukemiaRICHES, John C; RAMSAY, Alan G; GRIBBEN, John G et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 23, pp 3389-3398, issn 1381-6128, 10 p.Article